High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma

Oncogene

Volumn 19, Issue 5, 2000, Pages 617-623

  Islam, Ashraful ^a,b   Kageyama, Hajime ^a   Takada, Naoyuki ^a   Kawamato, Takemasa ^a   Takayasu, Hajime ^a,b   Isogai, Eriko ^a   Ohira, Miki ^a   Hashizume, Kohei ^b   Kobayashi, Hirofumi ^c   Kaneko, Yasuhiko ^c   Nakagawara, Akira ^a  

^a CHIBA CANCER CENTER   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c SAITAMA CANCER CENTER   (Japan)

Author keywords

17q gain; Apoptosis; Neuroblastoma; Prognostic factor; Survivin

Indexed keywords

INHIBITOR OF APOPTOSIS PROTEIN; MESSENGER RNA; RETINOIC ACID; SURVIVIN;

AGE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; CANCER STAGING; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME 17Q; CLINICAL ARTICLE; CONTROLLED STUDY; DNA TRANSFECTION; GENE EXPRESSION; GENE MAPPING; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS;

INTRACISTERNAL A-PARTICLES; SAL VIEJA VIRUS;

EID: 0034598797     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203358     Document Type: Article

References (26)

1. Adida C, Berrebi D, Peuchmaur M, Reyes-Mugica M and Altieri DC. (1998b). Lancet, 351, 882-883.
2. Adida C, Crotty PL, McGrath J, Diebold J and Altieri DC. (1998a). Am. J. Pathol., 152, 43-49.
3. Ambrosini G, Adida C and Altieri DC. (1997). Nat. Med., 3, 917-921.
4. Ambrosini G, Adida C, Sirugo G and Altieri DC. (1998). J. Biol. Chem., 18, 11177-11182.
5. Barinaga M. (1998). Science, 280, 32-35.
6. Brodeur GM, Pritchard J, Berthold F, Carlsen NLT, Castel V, Castleberry RP, Bernardi BD, Evans AE, Favrot M, Hedborg F, Kaneko M, Tsuchida Y, Philip T, Ronald B and Voute PA. (1993). J. Clin. Oncol., 11, 1466-1477.
7. Brown N, Cotterill S, Lastowska M, O'Neill S, Pearson ADJ, Plantaz D, Meddeb M, Danglot G, Brinnkschmidt C, Christiansen H, Laureys G and Speleman F. (1999). N. Eng. J. Med., 340, 1954-1961.
8. Caron H. (1995). Med. Pediatr. Oncol., 24, 215-221.
9. Chomczynski P and Sacchi N. (1987). Anal. Biochem., 162, 156-159.
10. Christiansen H, Schestag J, Christiansen NM, Grzeschik K and Lampert F. (1992). Genes Chromosom. Cancer, 5, 141-149.
11. Hoehner JC, Gestblom C, Olsen L and Pahlman S. (1997). Br. J. Cancer, 75, 1185-1194.
12. Inazawa J, Saito H, Ariyama T, Abe T and Nakamura Y. (1993). Genomics, 17, 153-162.
13. Ioannou PA, Amemiya CT, Garnes J, Kroisel PM, Shizuya H, Chen C, Batzer MA and de Jong PJ. (1994). Nat. Genet., 6, 84-89.
14. Kaneko M, Nishihira H, Mugishima H, Ohnuma N, Nakada K, Kawa K, Fukuzawa M, Suita S, Sera Y and Tsuchida Y. (1998). Med. Pediatr. Oncol., 31, 1-7.
15. Kobayashi H, Satake N, Maseki N, Sakashita A and Kaneko Y. (1996). Brit. J. Haematol., 94, 105-111.
16. Lastowska M, Roberts P, Pearson AD, Lewis I, Wolstenholms J and Bown N. (1997). Genes Chromosomes Cancer, 19, 143-149.
17. Li F, Ambrosini G, Chu EY, Plesica J, Tognin S, Marchisio PC and Altieri DC. (1998). Nature, 396, 580-584.
18. Lu C, Altieri DC and Tanigawa N. (1998). Cancer Res., 58, 1808-1812.
19. Nakagawara A. (1998a). Med. Pediatr. Oncol., 31, 113-115.
20. Nakagawara A. (1998b). Hum. Cell, 3, 115-124.
21. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB and Brodeur GM. (1993). N. Engl. J. Med., 328, 847-854.
22. Nakagawara A, Nakamura Y, Ikeda H, Hiwasa T, Kuida K, Su A, Zhao H, Cnaan A and Sakiyama S. (1997). Cancer Res., 57, 4578-4584.
23. Plantaz D, Mohapatra G, Matthay KK, Pellarin M, Seeger RC and Feuerstein BG. (1997). Am. J. Pathol., 150, 81-89.
24. Reed JC. (1994). J. Cell Biol., 124, 1-4.
25. Shimada H, Chatten J, Newton Jr WA, Sachs N, Hamoudi AB, Chiba T, Marsden HB and Misugi K. (1984). J. Natl. Cancer Inst., 73, 405-416.
26. Yang E and Korsmeyer SJ. (1996). Blood, 88, 386-401.